COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 122 clinical trials
Toothbrushing Program in Saudi Arabia "TOPS"- A Cluster Randomized Controlled Trial in Kindergartens, Riyadh

Project summary Introduction: Dental caries is a major oral health problem worldwide. In children, dental caries is especially critical; it causes pain, infection and impacts on quality of life and it can potentially impact children's growth, nutrition, and educational attainment. Children in Saudi Arabia have among the highest caries levels …

Accepts healthy volunteers
  • 0 views
  • 17 Sep, 2022
  • 0 views
  • 14 Sep, 2022
  • 100 locations
  • 1 views
  • 21 Sep, 2022
  • 80 locations
A Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab 100 mg in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent COPD Exacerbations and Elevated Peripheral Blood Eosinophils (RESOLUTE) (RESOLUTE)

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood

severe chronic obstructive pulmonary disease
bronchodilator
eosinophil count
antibiotics
corticosteroids
  • 1764 views
  • 19 Sep, 2022
  • 294 locations
A Phase 2a, Open-label, Two-part Study to Evaluate the Mechanism of Action of Itepekimab (Anti-IL-33 mAb) on Airway Inflammation in Patients With Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-3)

This study is an exploratory, two-part, 12-week, Phase 2a study to evaluate the mechanism of action of Itepekimab and its impact on airway inflammation in former and current smokers with COPD

  • 0 views
  • 09 Sep, 2022
  • 3 locations
A Phase 2a, Open-label, Two-part Study to Evaluate the Mechanism of Action of Itepekimab (Anti-IL-33 mAb) on Airway Inflammation in Patients With Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-3)

This study is an exploratory, two-part, 12-week, Phase 2a study to evaluate the mechanism of action of Itepekimab and its impact on airway inflammation in former and current smokers with COPD

  • 0 views
  • 20 Sep, 2022
  • 6 locations
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) (PERFECT)

Distance (6MWD) following 12 weeks of active treatment in participants with PH-COPD.

right heart catheterization
forced expiratory volume
diuretics
vasodilator
left ventricular end-diastolic pressure
  • 2674 views
  • 15 Sep, 2022
  • 66 locations
  • 415 views
  • 17 Sep, 2022
  • 75 locations
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation (NOTUS)

Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary Disease (COPD) as measured by

  • 51 views
  • 09 Sep, 2022
  • 218 locations
  • 22 views
  • 19 Sep, 2022
  • 207 locations